Sleep Solutions, the pioneer and largest national service provider of home sleep tests for obstructive sleep apnea, has changed its name to NovaSom.
__________

Sleep Solutions, the pioneer and largest national service provider of home sleep tests for obstructive sleep apnea, has changed its name to NovaSom.
ResMed Corp. today released the new Mirage SoftGel nasal mask, the latest in its line of market-leading nasal interfaces for use in the treatment of sleep apnea.

Royal Philips Electronics has released the BiPAP autoSV Advanced, its latest device for treating complicated sleep-disordered breathing patients.
The system is designed to effectively manage challenging sleep apnea cases.

Philips Respironics has introduced the EasyLife nasal mask for the treatment of obstructive sleep apnea (OSA).
The EasyLife is a nasal mask that is used to deliver positive airway pressure in the treatment of obstructive sleep apnea for patients weighing more than 66 pounds.
Royal Philips Electronics today showcased the next generation Philips Respironics Sleep Therapy System at Medtrade 2009, a conference and expo for the home medical equipment industry.
The arrival of the new product line brings advances in sleep apnea therapy, the manufacturer says, that will benefit millions of sleep apnea sufferers, as well as bring new solutions to healthcare providers trying to meet today’s healthcare challenges.

ResMed Corp. has released the Mirage SoftGel nasal mask, the latest in its line of nasal interfaces for use in the treatment of sleep apnea. The SoftGel is designed to offer exceptional comfort and versatility for patients and healthcare providers.

Royal Philips Electronics has appointed Eoghan O’Lionaird to lead Philips Home Healthcare Solutions’ Sleep business as Senior Vice President and General Manager, effective immediately.
“We are delighted to have Eoghan [pronounced “Owen”] take over the reins of our sleep business,” says Don Spence, Chief Executive Officer, Philips Home Healthcare Solutions.
Embla and Covidien have entered into a definitive agreement under which Embla will acquire Covidien’s Sleep Diagnostic business.
This includes the sleep diagnostic products sold under the Sandman brand name. Financial terms of the transaction were not disclosed. Completion of the sale is subject to customary closing conditions.
As of May 2, 2009 at 9:47 p.m. (-0500) (ET), the U.S. population
was 306,340,710. Sleep researchers estimate approximately seven percent
of the population suffers from obstructive sleep apnea. Using that
estimate, there are potentially 21,443,850 apneics in the U.S.
~~ Apnea around the world ~~
As of May 2, 2009 at 9:47 p.m. (-0500) (ET), the world population
was 6,777,286,604. Sleep researchers estimate approximately seven percent
of the population suffers from obstructive sleep apnea. Using that
estimate, there are potentially 474,410,062 apneics in the world.